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SUMMARY
Contemporary leadless pacemakers only feature single-chamber pacing capability. This study presents a prototype of a leadless dual-chamber pacemaker. Highly energy-efficient intrabody communication was implemented for wireless pacemaker synchronization. Optimal communication parameters were obtained by in vivo and ex vivo measurements in the heart and blood. The prototype successfully performed dual-chamber pacing To overcome these limitations, leadless singlechamber PMs have been introduced. These devices are implanted inside the right ventricle using dedicated delivery catheters. In addition to offering a cosmetic benefit, the leadless design and the lack of a surgically created subcutaneous pocket eliminate major drawbacks. To date, 2 leadless PMs are commercially available: Micra (Medtronic, Minneapolis, Minnesota) and Nanostim (St. Jude Medical, St. Paul, Minnesota) (4) (5) (6) (7) (8) . However, these devices have the significant limitation of performing single-chamber ventricular pacing only. Therefore, present leadless PMs are not well suited for the majority of patients in whom a dual-chamber system or cardiac resynchronization therapy is preferred due to medical reasons (9).
Communication between different pacing sites is also key to reducing right ventricular pacing. Hence, dual-chamber pacing systems that profit from the advantages of leadless PMs are highly desirable.
The concept proposed in the present study involves multiple implanted leadless PMs that jointly act as a leadless dual-chamber PM system ( Figure 1 ).
To preserve synchrony, these devices must communicate wirelessly with each other. A typical communication scenario in a leadless dual-chamber PM system could work as follows: the atrial PM stimulates the right atrium (RA) and immediately sends a synchronization message to the ventricular PM that comprises information such as the atrioventricular pacing delay. This message is received almost instantly by the ventricular PM, which reacts accordingly within the same heart cycle. Therefore, the connection has to be established in a very short time although the amount of transferred data is very small. Furthermore, leadless PMs consume only 5 to 10 mW of power (according to device manufacturer's reference manuals), which is important due to the highly restricted battery volume. Therefore, the communication must be very energy efficient and should not significantly reduce the lifetime of a PM.
Inside the body, these requirements can typically not be met with wireless data communications based on radiofrequency telemetry and inductive coupling (as used by conventional cardiac implantable devices) (10, 11) . In contrast, galvanic coupled intrabody communication (12) is a promising approach for wireless data transfer between implanted devices.
It uses the tissue as a transmission medium for electrical signals: the data from one device are modulated and applied as a small alternating current signal to the tissue via electrodes. This current will propagate in the tissue and can be registered almost simultaneously by another device.
Galvanic coupled intrabody communication has
mainly been investigated as a wireless communication method for on-body biomedical sensor networks (10, 12) . To characterize the human body as a transmission medium for electrical current, tissue properties and geometrical alignment influences have been investigated. However, most studies focus on transmission between body extremities using surface electrodes (13) (14) (15) . For the proposed communication between leadless PMs, the dominant transmission medium is the myocardium/blood, and the communication electrodes are preferably the PM electrodes.
In the present study, the heart's electrical signal transmission characteristics were assessed to develop a prototype of a leadless dual-chamber PM using intrabody communication for device synchronization. The PM underwent in vivo testing to investigate the method's acute safety and ability to allow multisite pacing. 
METHODS

IMPEDANCE AND TRANSFER FUNCTION MEASUREMENTS.
To build the wireless dual-chamber PM, we first investigated the key characteristics for intrabody communication inside the heart. The impedance between the communication electrodes Z e is a first key parameter to be characterized. It is mainly defined by the surrounding tissue, the electrode distance (d e ), and the electrode penetration depth (d p ) (Figure 2) . depth (dp). The signal attenuation in the tissue is defined by the relation of the voltages V transmitter and V receiver .
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Federal Veterinary Office and performed in compli-
ance with the Guide for the Care and Use of Laboratory Animals.
Leadless PMs are mainly surrounded by blood.
Hence, the transfer function of porcine blood was measured in addition to the heart measurements. A container (100 ml volume) was filled with heparinized 
RESULTS
IMPEDANCE AND TRANSFER FUNCTION MEASUREMENTS.
Measurements on 7 beating hearts (4 in vivo, 3 in a Due to contraction of the heart and the resulting deformation of the myocardium, the attenuation varies during the heart cycle. This variation remained <5 dB. This corresponds to a signal transmission improvement of 250% and 40%, respectively.
The impedance Z e is decreasing with higher frequencies. For the given dimensions, the measured impedance of heart tissue is in the range of 400 to 1,000 U for frequencies between 100 kHz and 1 MHz.
The impedance is lower for smaller electrode distances and for higher electrode penetration depths (i.e., higher electrode contact surface area). Furthermore, it depends on the surrounding medium. The impedance of blood is generally lower compared with the myocardium, whereas the transfer function is comparable.
PROTOTYPES. The PM prototypes ( Figure 6A ) can communicate wirelessly via the heart by using intra- The dependence of the attenuation on the relative spatial PM position also affects energy consumption.
In general, a higher signal attenuation requires either a higher transmitter power or a more powerful amplifier on the receiving PM. In a real-world setting, these parameters could be dynamically adapted to optimize power consumption. Due to contraction of the heart and movement of the PMs, signal attenuation can even vary during a heartbeat.
In the performed experiments, this variation was small (<5 dB), but it might be higher in different This study presents a leadless dual-chamber PM.
By implanting an additional leadless PM in the LV that communicates with the other 2 devices, the presented concept might also be extended to a leadless cardiac resynchronization therapy system. Bereuter et al.
